Management Of Tyrosine Kinase Inhibitor–Induced Hand–Foot Skin Reaction: Viewpoints from the Medical Oncologist, Dermatologist, and Oncology Nurse
Author:
Publisher
Elsevier BV
Subject
Pharmacology (medical),Oncology
Reference49 articles.
1. Uncovering Pandora's vase: the growing problem of new toxicities from novel anticancer agents;Porta;Clin Exp Med,2007
2. Hand–foot syndrome (hand–foot skin reaction, palmar–plantar erythrodysesthesia): focus on sorafenib and sunitinib;Lipworth;Oncology,2009
3. Evolving strategies for the management of hand–foot skin reaction associated with the multitargeted kinase inhibitors sorafenib and sunitinib;Lacouture;Oncologist,2008
4. Preclinical overview of sorafenib, a multikinase inhibitor that targets both Raf and VEGF and PDGF receptor tyrosine kinase signaling;Wilhelm;Mol Cancer Ther,2008
5. Antitumor activity of sorafenib in FLT3-driven leukemic cells;Auclair;Leukemia,2007
Cited by 36 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Exploring the Spectrum of VEGF Inhibitors’ Toxicities from Systemic to Intra-Vitreal Usage in Medical Practice;Cancers;2024-01-13
2. Validation of the prophylactic efficacy of urea‐based creams on sorafenib‐induced hand‐foot skin reaction in patients with advanced hepatocellular carcinoma: A randomised experiment study;Cancer Reports;2021-12-14
3. Strategies to improve sorafenib efficacy during image-guided treatment of hepatocellular carcinoma;Annals of Translational Medicine;2021-12
4. Expert consensus on the management of adverse events in patients receiving lenvatinib for hepatocellular carcinoma;Journal of Gastroenterology and Hepatology;2021-11-17
5. Do we need skin toxicity? Association of immune checkpoint inhibitor and tyrosine kinase inhibitor‐related cutaneous adverse events with outcomes in metastatic renal cell carcinoma;International Journal of Dermatology;2021-04-19
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3